Combined Research Orlando

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Depression2 trials
• Insomnia1 trial
• Schizophrenia1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Intra-Cellular Therapies, Inc.2 trials
• Janssen Research & Development, LLC2 trials
• University of Arizona1 trial

Running trials

• Active, not recruiting

  Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

  NCT04838301· Phase 2· University of Arizona· Source

Closed trials

• Recruiting

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

  NCT06651567· Phase 2· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  NCT06540833· Phase 2· Intra-Cellular Therapies, Inc.· Source

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· Phase 3· Janssen Research & Development, LLC· Source